Treace Medical Concepts, Inc. Common Stock
TMCIStock
$4.43−25.88%52W
Market Cap$285.44M
P/E—
Div yield—
Beta1.40
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)43.38%
Price vs S&P 500 (4W)13.66%
VGM Score60.43
Market Capitalization$285.44M
Earnings Surprise History
Q1 26-0.28est. -0.31
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
2.50
2.50
2.50
2.50
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TMCITreace Medical Concepts, Inc. Common Stock | B | C | B | $4.43 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Treace Medical Concepts develops and commercializes the Lapiplasty 3D Bunion Correction procedure, a patented surgical solution for treating bunion deformities. The procedure addresses the underlying cause of bunions across all planes of deformity while enabling patients to return to normal activities quickly. The company markets its devices to surgeons, ambulatory surgery centers, and hospitals in the large and growing orthopedic foot surgery market.